Clinical trial
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
NCT03904134 is registered in ClinicalTrials.gov with Center for International Blood and Marrow Transplant Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
- Lead sponsor
- Center for International Blood and Marrow Transplant Research
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 14, 2019
- Completion date
- January 6, 2025
- Enrollment
- 1,753 (actual)
- Sites
- 52
Conditions
As the registry lists them; a condition with its own page is linked.
acquired aplastic anemia, acute lymphoblastic leukemia, acute myeloid leukemia, hodgkin lymphoma, myelodysplastic syndromes, non-hodgkin lymphoma, sickle cell disease